All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-18304321

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	18304321	A62V	RT	gag-pol	HIV Infections	D G R S I C L T	View
2	18304321	D218E	RT	gag-pol	HIV Infections	D G R S I C L T	View
3	18304321	F214L	RT	gag-pol	HIV Infections	D G R S I C L T	View
4	18304321	I10V	RT	gag-pol	HIV Infections	D G R S I C L T	View
5	18304321	I54M	PR	gag-pol	HIV Infections	D G R S I C L T	View
6	18304321	I89V	PR	gag-pol	HIV Infections	D G R S I C L T	View
7	18304321	I90V	RT	gag-pol	HIV Infections	D G R S I C L T	View
8	18304321	K35R	RT	gag-pol	HIV Infections	D G R S I C L T	View
9	18304321	K35T	RT	gag-pol	HIV Infections	D G R S I C L T	View
10	18304321	K45R	PR	gag-pol	HIV Infections	D G R S I C L T	View
11	18304321	K64R	RT	gag-pol	HIV Infections	D G R S I C L T	View
12	18304321	K65R	RT	gag-pol	HIV Infections	D G R S I C L T	View
13	18304321	K70N	RT	gag-pol	HIV Infections	D G R S I C L T	View
14	18304321	K82R	RT	gag-pol	HIV Infections	D G R S I C L T	View
15	18304321	L90M	PR	gag-pol	HIV Infections	D G R S I C L T	View
16	18304321	L99F	PR	gag-pol	HIV Infections	D G R S I C L T	View
17	18304321	M184I	RT	gag-pol	HIV Infections	D G R S I C L T	View
18	18304321	M184V	RT	gag-pol	HIV Infections	D G R S I C L T	View
19	18304321	N69S	RT	gag-pol	HIV Infections	D G R S I C L T	View
20	18304321	N69T	RT	gag-pol	HIV Infections	D G R S I C L T	View
21	18304321	Q151M	RT	gag-pol	HIV Infections	D G R S I C L T	View
22	18304321	S215T	RT	gag-pol	HIV Infections	D G R S I C L T	View
23	18304321	S43I	PR	gag-pol	HIV Infections	D G R S I C L T	View
24	18304321	T56A	PR	gag-pol	HIV Infections	D G R S I C L T	View
25	18304321	V111I	RT	gag-pol	HIV Infections	D G R S I C L T	View
26	18304321	V47A	PR	gag-pol	HIV Infections	D G R S I C L T	View
27	18304321	V62A	PR	gag-pol	HIV Infections	D G R S I C L T	View
28	18304321	V62M	PR	gag-pol	HIV Infections	D G R S I C L T	View
29	18304321	V71I	PR	gag-pol	HIV Infections	D G R S I C L T	View
30	18304321	V71T	PR	gag-pol	HIV Infections	D G R S I C L T	View
31	18304321	V83I	RT	gag-pol	HIV Infections	D G R S I C L T	View
32	18304321	Y115F	RT	gag-pol	HIV Infections	D G R S I C L T	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.